Prokidney (PROK) Accumulated Depreciation (2021 - 2025)
Prokidney (PROK) reported Accumulated Depreciation of $16.6 million for Q4 2025, up 50.04% year-over-year from $11.0 million in Q4 2024, and up 19.24% quarter-over-quarter from $13.9 million in Q2 2025.
Prokidney (PROK) Accumulated Depreciation (2021 - 2025) Analysis & Trends
Prokidney (PROK) has 5 years of Accumulated Depreciation data on file, last reported at $16.6 million in Q4 2025.
- Accumulated Depreciation for Q4 2025 came in at $16.6 million, up 50.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $16.6 million (up 50.04% YoY), and the FY2025 annual result was $16.6 million, up 50.04% from the prior year.
- Accumulated Depreciation climbed to $16.6 million in Q4 2025 per PROK's latest filing, from $13.9 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $16.6 million in Q4 2025 and troughed at $2.3 million in Q4 2021.
- A 5-year average of $8.5 million and a median of $8.0 million in 2023 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2022 and 2024: Accumulated Depreciation soared 108.41% in 2022, then surged 44.36% in 2024.
- A 5-year view of Accumulated Depreciation shows it stood at $2.3 million in 2021, then jumped by 108.41% to $4.7 million in 2022, then jumped by 62.32% to $7.6 million in 2023, then jumped by 44.36% to $11.0 million in 2024, then jumped by 50.04% to $16.6 million in 2025.
- Business Quant data shows PROK's Accumulated Depreciation at $16.6 million in Q4 2025, $13.9 million in Q2 2025, and $12.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.55 Mn |
| Jun 30, 2025 | 13.88 Mn |
| Mar 31, 2025 | 12.41 Mn |
| Dec 31, 2024 | 11.03 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | 9.40 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Dec 31, 2023 | 7.64 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Jun 30, 2023 | 5.98 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 4.71 Mn |
| Sep 30, 2022 | 4.09 Mn |
| Dec 31, 2021 | 2.26 Mn |